Influence of the presence of methyl cyclodextrins in high-performance liquid chromatography mobile phases on the separation of β-carboline alkaloids

Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects

Many active pharmaceutical ingredients show low oral bioavailability due to factors such as poor solubility and physical and chemical instability. The formation of inclusion complexes with cyclodextrins, as well as cyclodextrin-based polymers, nanosponges, and nanofibers, is a valuable tool to improve the oral bioavailability of many drugs. The microencapsulation process modifies key properties of the included drugs including volatility, dissolution rate, bioavailability, and bioactivity. In this context, we present relevant examples of the stabilization of labile drugs through the encapsulation in cyclodextrins. The formation of inclusion complexes with drugs belonging to class IV in the biopharmaceutical classification system as an effective solution to increase their bioavailability is also discussed. The stabilization and improvement in nutraceuticals used as food supplements, which often have low intestinal absorption due to their poor solubility, is also considered. Cyclodextrin-based nanofibers, which are polymer-free and can be generated using environmentally friendly technologies, lead to dramatic bioavailability enhancements. The synthesis of chemically modified cyclodextrins, polymers, and nanosponges based on cyclodextrins is discussed. Analytical techniques that allow the characterization and verification of the formation of true inclusion complexes are also considered, taking into account the differences in the procedures for the formation of inclusion complexes in solution and in the solid state.

Cyclodextrins Initiated Ring-Opening Polymerization of Lactide Using 4-dimethylaminopyridine (DMAP) as Catalyst: Study of DMAP/β-CD Inclusion Complex and Access to New Structures

Cyclodextrins (CDs) are cyclic oligosaccharides used in many fields. Grafting polymers onto CDs enables new structures and applications to be obtained. Polylactide (PLA) is a biobased, biocompatible aliphatic polyester that can be grafted onto CDs by -OH-initiated ring-opening polymerization. Using 4-dimethylaminopyridine (DMAP) as an organocatalyst, a quantitative functionalization is reached on native α-, β-, γ- and 2,3-dimethyl- β-cyclodextrins. Narrow molecular weight distributions are obtained with the native CDs (dispersity < 1.1). The DMAP/β-CD combination is used as a case study, and the formation of an inclusion complex (1/1) is shown for the first time in the literature, which is fully characterized by NMR. The inclusion of DMAP into the cavity occurs via the secondary rim of the β-CD and the association constant (K_a) is estimated to be 88.2 M⁻¹. Its use as an initiator for ring-opening polymerization leads to a partial functionalization efficiency, and thus a more hydrophilic β-CD-PLA conjugate than that obtained starting from native β-CD. Polymerization results including also the use of the adamantane/β-CD inclusion complex as an initiator suggest that inclusion of the DMAP catalyst into the CD may not occur during polymerization reactions. Rac-lactide does not form an inclusion complex with β-CD.

Complexation with β-cyclodextrin enhances apoptosis-mediated cytotoxic effect of harman in chemoresistant BRAF-mutated melanoma cells

Harman, a natural β-carboline alkaloid, has recently gained considerable interest due to its anticancer properties. However, its physicochemical characteristics and poor oral bioavailability have been limiting factors for its pharmaceutical development. In this paper, we described the complexation of harman (HAR) with β-cyclodextrin (βCD) as a promising alternative to improve its solubility and consequently its cytotoxic effect in chemoresistant melanoma cells (A2058 cell line). Inclusion complexes (βCD-HAR) were prepared using a simple method and then characterized by FTIR, NMR and SEM techniques. Through in silico studies, the mechanism of complexation of HAR with βCD was elucidated in detail. Both HAR and βCD-HAR promoted cytotoxicity, apoptosis, cell cycle arrest and inhibition of cell migration in melanoma cells. Interestingly, complexation of HAR with βCD enhanced its pro-apoptotic effect by increasing of caspase-3 activity (p < 0.05), probably due to an improvement in HAR solubility. In addition, HAR and βCD-HAR sensitized A2058 cells to vemurafenib, dacarbazine and 5FU treatments, potentializing their cytotoxic activity. These findings suggest that complexation of HAR with natural polymers such as βCD can be useful to improve its bioavailability and antimelanoma activity.

Enantioseparation of Citalopram by RP-HPLC, Using Sulfobutyl Ether-β-Cyclodextrin as a Chiral Mobile Phase Additive

Enantiomeric separation of citalopram (CIT) was developed using a reversed phase HPLC (RP-HPLC) with sulfobutylether-β-cyclodextrin (SBE-β-CD) as a chiral mobile phase additive. The effects of the pH value of aqueous buffer, concentration of chiral additive, composition of mobile phase, and column temperature on the enantioseparation of CIT were investigated on the Hedera ODS-2 C₁₈ column (250 mm × 4.6 mm × 5.0 um). A satisfactory resolution was achieved at 25°C using a mobile phase consisting of a mixture of aqueous buffer (pH of 2.5, 5 mM sodium dihydrogen phosphate, and 12 mM SBE-β-CD), methanol, and acetonitrile with a volumetric ratio of 21 : 3 : 1 and flow rate of 1.0 mL/min. This analytical method was evaluated by examining the precision (lower than 3.0%), linearity (regression coefficients close to 1), limit of detection (0.070 µg/mL for (R)-CIT and 0.076 µg/mL for (S)-CIT), and limit of quantitation (0.235 µg/mL for (R)-CIT and 0.254 µg/mL for (S)-CIT).

The use of methyl-β-cyclodextrin to solubilize cholesterol prior to coating onto a C18 stationary phase

The use of methyl-β-cyclodextrin (MBCD) as a mobile phase additive in reversed-phase liquid chromatography is explored, with the primary goal of using MBCD to solubilize cholesterol in reversed-phase mobile phases for cholesterol-coating of C18 stationary phases. MBCD is shown to increase the solubility of cholesterol in typical reversed-phase mobile phases, especially when the stoichiometric ratio of MBCD to cholesterol exceeds 2:1. Additional equivalents of MBCD further increase solubility, or allow for weaker solvents to be used. The use of weaker solvents allows for larger coating levels of cholesterol onto a C18 stationary phase than are possible without the use of MBCD. Stationary phases coated with cholesterol using MBCD as a co-additive have different selectivity than uncoated phases, especially with regards to phenyl and shape selectivity. Further, the use of MBCD as a mobile phase additive for the elution of cholesterol is examined. It is seen via van't Hoff analysis that the reduction in retention of cholesterol when MBCD is added to the mobile phase is enthalpically driven.

Eco-friendly separation of catechins using cyclodextrins as mobile phase additives in RP-HPLC

BACKGROUND

New mobile phases for RP-HPLC were developed for the separation of catechin compounds in tea. Cyclodextrin mobile phase additives decreased the use of toxic and inflammable organic solvents without compromising resolution or separation efficiency.

AIMS

To develop a simple greener method for analyzing five tea catechins in RP-HPLC, the mobile phase condition was optimized and the lowest organic modifier proportion with content resolutions and retention factors were obtained.

MATERIALS & METHODS

Eco-friendly cyclodextrins were used as mobile phase additives to decrease the proportion of organic modifier and improve resolutions and retention factors.

RESULTS

The effects of several physico-chemical parameters on the retention factors were investigate d and the optimum conditions were obtained on a conventional C₁₈ column, where the mobile phase consisted of acetonitrile/water (12/88, v/v) with 1.5 mmol/L β-cyclodextrin at a flow rate of 1.0 mL/min.

DISCUSSION

Cyclodextrins can separate analytes through host-guest complexation, where a transient diastereomeric complex is formed between the cyclodextrin and the analyte. β-Cyclodextrin is the most accessible, the least expensive and generally the most useful cyclodextrin.

CONCLUSION

This work developed a simple eco-friendly method with the lowest concentration of organic solvents. Under the optimal condition, five catechins could be baseline separated within 17 minutes in the isocratic mode. This research exhibited the potential for the separation and determination of other active compounds from natural plants by a greener method.